Vaxcyte, Inc. PCVX
56.21
(0.69)
(1.21%)
as of 25 Sep
- Market cap
- $8.5B
- P/E
- 0.0×
Follow PCVX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
7.91 | 12.75 | 7.54 | 23.26 | 8.93 | 8.30 | 5.58 | 9.93 | — |
Net Debt/EBITDA |
1.71 | 2.95 | 2.19 | 4.16 | 2.49 | 4.38 | 1.11 | 1.92 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.86 | 0.98 | 0.74 | 0.76 | 1.21 | 0.52 | 0.94 | 1.03 | — |
Capex/Depreciation |
(1.32) | 0.98 | 0.65 | (0.69) | (1.34) | (0.79) | (0.97) | (1.71) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (25.59%) | (20.41%) | (36.67%) | (36.11%) | (31.78%) | (74.51%) | 61.27% | 35.94% | — | |
| (23.54%) | (18.86%) | (33.33%) | (33.59%) | (27.91%) | (38.91%) | (73.66%) | (83.29%) | — | |
ROIC |
(51.34%) | (22.84%) | (182.55%) | (652.79%) | (170.29%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(45.66%) | (25.13%) | (39.05%) | (24.49%) | (42.48%) | (25.83%) | (92.99%) | (46.53%) | — |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(4.92) | (3.89) | (3.22) | (2.72) | (2.46) | (1.62) | (12.74) | (8.88) | — |
Cash per Share |
11.47 | 14.32 | 11.12 | 14.36 | 4.74 | 13.07 | 15.54 | 18.21 | — |
Shareholders Equity per Share |
19.73 | 27.10 | 12.77 | 14.70 | 5.47 | 11.71 | 14.21 | 16.55 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
19.73 | 27.10 | 12.77 | 14.70 | 5.47 | 11.71 | 14.21 | 16.55 | — |
Free Cash Flow |
(669.29) | (475.05) | (312.85) | (176.44) | (127.92) | (47.73) | (48.34) | (32.24) | — |
Working Capital |
1,421.61 | 1,647.81 | 950.62 | 902.03 | 227.63 | 342.14 | 50.67 | 59.96 | — |
Capital Expenditures |
(13.71) | (22.43) | (16.06) | (5.84) | (6.53) | (1.10) | (1.19) | (1.77) | — |
Net Current Asset Value |
1,310.15 | 1,582.49 | 928.51 | 889.99 | 216.03 | 342.02 | 49.96 | 55.95 | — |
| Other line items | |||||||||
Quick Ratio |
7.59 | 12.46 | 7.43 | 22.98 | 8.57 | 8.24 | 5.34 | 9.85 | — |
Depreciation/Fixed assets |
0.04 | (0.12) | (0.31) | 0.82 | 0.61 | 0.43 | 0.36 | 0.30 | — |
Cash ROIC |
(21.50%) | (12.88%) | (16.22%) | (9.60%) | (24.41%) | (6.82%) | (44.76%) | (26.85%) | — |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(4.82) | (3.71) | (3.05) | (2.63) | (2.34) | (1.58) | (12.42) | (8.39) | — |
Capex per Share |
(0.10) | (0.18) | (0.17) | (0.09) | (0.13) | (0.04) | (0.31) | (0.49) | — |
Average Receivables |
— | — | — | 1.00 | 0.50 | 0.00 | 0.25 | — | — |
Average Payables |
59.68 | 31.52 | 12.19 | 8.28 | 18.27 | 16.58 | 3.10 | 3.10 | — |
Average Assets |
3,257.02 | 2,459.62 | 1,207.05 | 665.26 | 358.58 | 229.26 | 68.25 | 35.40 | — |
Average Common Equity |
2,995.66 | 2,273.14 | 1,097.04 | 618.82 | 314.93 | 119.74 | (82.05) | (82.05) | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates